Aptevo Therapeutics Competitors and Similar CompaniesClear all
Aptevo Therapeutics's competitors and similar companies include Olema Oncology and ImmunoGen.
 Aptevo Therapeutics Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. |  Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. |  ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. | |
Founding Date | Founding Date 2016 | Founding Date 2007 | Founding Date 1981 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Seattle, US HQ | Locations San Francisco, US HQ San Francisco, US | Locations Waltham, US HQ |
Employees | Employees 1182% decrease | Employees 9630% increase | Employees 277161% increase |
Valuation ($) | Valuation ($) 4.1 m | Valuation ($) 679.2 m | Valuation ($) 8.7 b |
Financial | |||
Net income | Net income ($26m) (FY, 2025) | Net income ($162.5m) (FY, 2025) | Net income ($222.9m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 145.1m | Total funding raised $ 56m |
For sources of this data, please see the company profile
View Company Profiles
Olema Oncology
HQ
San Francisco, US
Employees
96↑ 30% increase
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
View companyImmunoGen
HQ
Waltham, US
Employees
277
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View company